Article(id=1327673695620935695, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327673646463693422, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2022.01.004, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1615219200000, receivedDateStr=2021-03-09, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794471676020, onlineDateStr=2026-11-12, pubDate=1641744000000, pubDateStr=2022-01-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794471676020, onlineIssueDateStr=2026-11-12, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794471676020, creator=13701087609, updateTime=1794471676020, updator=13701087609, issue=Issue{id=1327673646463693422, tenantId=1146029695717560320, journalId=1319690259887390882, year='2022', volume='53', issue='1', pageStart='1', pageEnd='162', issueExtLink='null', onlineDate='null', pubDate='1641744000000', pubDateStr='2022-01-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794471664300, creator='13701087609', updateTime=1794472322938, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1327676409373372477, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327673646463693422, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1327676409373372478, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327673646463693422, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=48, endPage=55, ext={EN=ArticleExt(id=1327673697332211728, articleId=1327673695620935695, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Recent Advances in Abuse-deterrent Opioid Analgesics and Patent Analysis, columnId=1327671134809600231, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Opioid analgesics are efficient drugs for moderate-to-severe pain treatment. However, they also become commonly abused drugs due to their potential addiction. Prescription opioids abuse has become a global health crisis with increasing clinical use. The development of prescription opioids with abuse-deterrent formulations(ADFs) has been encouraged by the U. S. government to reduce the abuse of prescription opioids, so the United States is a recognized leader in discovering the new dosage forms of opioid analgesics around the world. To deter prescription opioids abuse, a variety of anti-abuse technologies have been developed, including forming physical/chemical barriers, adding agonists/antagonists, adding aversions, and preparing prodrugs. Although several approved opioid ADFs have been withdrawn from the market for different reasons, ADFs have played a positive role in lowering overall abuse risks. This review summarizes the recent development of abuse-deterrent opioid analgesics and analyzes the patents of critical products, hoping to provide some references for the research and development of ADFs in China.

, authors=Shengnan ZHU, Weijuan PENG, Xiangyang XU*, authorsList=Shengnan ZHU, Weijuan PENG, Xiangyang XU, authorCompany=null, correspAuthors=Xiangyang XU, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1327673697860694033, articleId=1327673695620935695, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=防滥用阿片类镇痛药研究进展及专利分析, columnId=1327671135019315436, journalTitle=中国医药工业杂志, columnName=综述, runingTitle=null, highlight=null, articleAbstract=

阿片类镇痛药是治疗中至重度疼痛的有效药物,但其潜在的成瘾性也使之成为常见的被滥用药物。随着阿片类药物使用的增加,滥用所导致的社会问题在全球范围内不断凸显。美国在阿片类药物防滥用制剂开发方面处于世界领先水平,为减少阿片类药物滥用,率先鼓励开发防滥用阿片类镇痛药。目前已开发了多种防滥用技术,包括形成物理/化学屏障、添加激动药/拮抗药、添加厌恶剂和制备前体药物等。虽然部分防滥用阿片类药物因各种原因撤市,但是总体对遏制阿片类药物的滥用起到了积极作用。本综述总结了近几年防滥用阿片类镇痛药的最新研究进展,并对重点品种进行了专利分析,以期为国内防滥用制剂的研发提供参考。

, authors=朱胜男, 彭卫娟, 许向阳*, authorsList=朱胜男, 彭卫娟, 许向阳, authorCompany=null, correspAuthors=许向阳, authorNote=

朱胜男(1987-),女,硕士,工程师,从事新型镇痛药物的研究与开发。

, correspAuthorsNote=
许向阳(1971-),男,博士,研究员,从事药物新制剂、新剂型和新技术的研究。Tel:0516-66668239 E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=SKoIAnujzDcE04K8S1eYNg==, magXml=1zQ+6mE8IAXbLfBamPTyaw==, pdfUrl=null, pdf=vHHN3j4bjB2wjUhDAmjJ0Q==, pdfFileSize=1525747, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=fhoaxWbz24TJdw3RIsPcqA==, mapNumber=null, fund=null)}, authors=[Author(id=1327673698141712406, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327673698254958616, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, authorId=1327673698141712406, language=EN, stringName=Shengnan ZHU, firstName=Shengnan, middleName=null, lastName=ZHU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Nhwa Institute of Pharmaceutical Research, Jiangsu Nhwa Pharmaceutical Co., Ltd., Xuzhou 221116, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327673698334650393, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, authorId=1327673698141712406, language=CN, stringName=朱胜男, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=江苏恩华药业股份有限公司,恩华药物研究院,江苏 徐州 221116, bio={"content":"

朱胜男(1987-),女,硕士,工程师,从事新型镇痛药物的研究与开发。

"}, bioImg=null, bioContent=

朱胜男(1987-),女,硕士,工程师,从事新型镇痛药物的研究与开发。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327673698049437714, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, xref=null, ext=[AuthorCompanyExt(id=1327673698057826323, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, companyId=1327673698049437714, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Nhwa Institute of Pharmaceutical Research, Jiangsu Nhwa Pharmaceutical Co., Ltd., Xuzhou 221116), AuthorCompanyExt(id=1327673698066214932, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, companyId=1327673698049437714, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=江苏恩华药业股份有限公司,恩华药物研究院,江苏 徐州 221116)])]), Author(id=1327673698410147867, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327673698506616861, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, authorId=1327673698410147867, language=EN, stringName=Weijuan PENG, firstName=Weijuan, middleName=null, lastName=PENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Nhwa Institute of Pharmaceutical Research, Jiangsu Nhwa Pharmaceutical Co., Ltd., Xuzhou 221116, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327673698577920030, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, authorId=1327673698410147867, language=CN, stringName=彭卫娟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=江苏恩华药业股份有限公司,恩华药物研究院,江苏 徐州 221116, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327673698049437714, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, xref=null, ext=[AuthorCompanyExt(id=1327673698057826323, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, companyId=1327673698049437714, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Nhwa Institute of Pharmaceutical Research, Jiangsu Nhwa Pharmaceutical Co., Ltd., Xuzhou 221116), AuthorCompanyExt(id=1327673698066214932, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, companyId=1327673698049437714, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=江苏恩华药业股份有限公司,恩华药物研究院,江苏 徐州 221116)])]), Author(id=1327673698682777632, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=xuxiangyang@nhwa-group.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1327673698787635234, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, authorId=1327673698682777632, language=EN, stringName=Xiangyang XU, firstName=Xiangyang, middleName=null, lastName=XU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Nhwa Institute of Pharmaceutical Research, Jiangsu Nhwa Pharmaceutical Co., Ltd., Xuzhou 221116, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327673698858938403, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, authorId=1327673698682777632, language=CN, stringName=许向阳, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=江苏恩华药业股份有限公司,恩华药物研究院,江苏 徐州 221116, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327673698049437714, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, xref=null, ext=[AuthorCompanyExt(id=1327673698057826323, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, companyId=1327673698049437714, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Nhwa Institute of Pharmaceutical Research, Jiangsu Nhwa Pharmaceutical Co., Ltd., Xuzhou 221116), AuthorCompanyExt(id=1327673698066214932, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, companyId=1327673698049437714, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=江苏恩华药业股份有限公司,恩华药物研究院,江苏 徐州 221116)])])], keywords=[Keyword(id=1327673698959601700, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, language=EN, orderNo=1, keyword=abuse-deterrent), Keyword(id=1327673699030904869, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, language=EN, orderNo=2, keyword=prescription opioids), Keyword(id=1327673699085430822, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, language=EN, orderNo=3, keyword=analgesics), Keyword(id=1327673699139956775, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, language=EN, orderNo=4, keyword=patent analysis), Keyword(id=1327673699202871336, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, language=CN, orderNo=1, keyword=防滥用), Keyword(id=1327673699274174505, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, language=CN, orderNo=2, keyword=阿片类药物), Keyword(id=1327673699332894762, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, language=CN, orderNo=3, keyword=镇痛药), Keyword(id=1327673699391615019, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, language=CN, orderNo=4, keyword=专利分析)], refs=[Reference(id=1327673699576164397, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=MILER R D.米勒麻醉学(第7版上卷)[M].邓小明,曾因明,译.北京:北京大学医学出版社,2011:781-796., articleTitle=null, refAbstract=null), Reference(id=1327673699643273262, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=HAUMANN J, JOOSTEN E B A, VAN DEN BEUKEN-VAN EVERDINGEN M H J.Pain prevalence in cancer patients: status quo or opportunities for improvement? [J].Curr Opin Support Palliat Care, 2017, 11(2): 99-104., articleTitle=null, refAbstract=null), Reference(id=1327673699706187823, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=HANNA M, MOON J Y.A review of dexketoprofen trometamol in acute pain [J].Curr Med Res Opin, 2019,35(2): 189-202., articleTitle=null, refAbstract=null), Reference(id=1327673699777490992, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=世界卫生组织.阿片类药物过量[EB/OL].(2021-08-04).https://www.who.int/zh/news-room/fact-sheets/detail/opioid-overdose., articleTitle=null, refAbstract=null), Reference(id=1327673699840405553, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=佚名.新冠肺炎对毒品市场的影响[EB/OL].[2021-04-07].https://wdr.unodc.org/wdr2020/field/V2002973_Exum_Chinese.pdf., articleTitle=null, refAbstract=null), Reference(id=1327673699903320114, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=ADLER J A, MALLICK-SEARLE T.An overview of abuse-deterrent opioids and recommendations for practical patient care [J].J Multidiscip Healthc, 2018, 11: 323-332., articleTitle=null, refAbstract=null), Reference(id=1327673701568458803, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=CARINCI A J.Abuse-deterrent opioid analgesics: a guide for clinicians [J].Pain manag, 2020, 10(1): 55-62., articleTitle=null, refAbstract=null), Reference(id=1327673701677510708, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=GADD S, COX N, SAMUELSON J, et al.Abuse-deterrent opioid formulations and the opioid crisis: a pharmacist's perspective [J].Ther Drug Monit, 2021, 43(1): 35-41., articleTitle=null, refAbstract=null), Reference(id=1327673701757202485, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=孟莉萍,王广平,易八贤.遏制滥用型阿片类镇痛药的研发进展[J].中国新药杂志,2015,24(18):2110-2121., articleTitle=null, refAbstract=null), Reference(id=1327673701870448694, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=BUTREDDY A, NYAVANANDI D, NARALA S, et al.Application of hot melt extrusion technology in the development of abuse-deterrent formulations: an overview[J].Curr Drug Deliv, 2021, 18(1): 4-18., articleTitle=null, refAbstract=null), Reference(id=1327673701941751863, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=徐一洲,柴旭煜,王健.阿片类药物防滥用技术研究进展[J].中国医药工业杂志,2021,52(6):719-727., articleTitle=null, refAbstract=null), Reference(id=1327673702021443640, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=WEN L S, SADEGHI N B.The opioid crisis and the 2020 US election: crossroads for a national epidemic [J].Lancet,2020, 396(10259): 1316-1318., articleTitle=null, refAbstract=null), Reference(id=1327673702109524025, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=央视新闻客户端.美国阿片类药物滥用危机正在恶化专家:政府解决问题就像“拆东墙补西墙”[EB/OL].[2021-02-08].https://m.news.cctv.com/2020/09/13/ARTIJLmXEgxUSsfRBxivvZbp200913.shtml., articleTitle=null, refAbstract=null), Reference(id=1327673702201798714, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=U.S. Food and Drug Administration.Guidance for industry: abuse-deterrent opioids — evaluation and labeling [EB/OL].[2021-01-28].https://www.fda.gov/regulatory-information/search-fda-guidance-documents/abuse-deterrent-opioids-evaluation-and-labeling., articleTitle=null, refAbstract=null), Reference(id=1327673702277296187, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=U.S. Food and Drug Administration.Guidance for industry: general principles for evaluating the abuse deterrence of generic solid oral opioid drug products [EB/OL].[2021-01-28].https://www.fda.gov/regulatory-information/search-fda-guidance-documents/general-principles-evaluating-abuse-deterrence-generic-solid-oral-opioid-drug-products-guidance., articleTitle=null, refAbstract=null), Reference(id=1327673702352793660, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=支梦佳,魏兴梅,高翔,等.我国阿片类镇痛药物临床使用现状分析[J].药物流行病学杂志,2018,27(6):400-405., articleTitle=null, refAbstract=null), Reference(id=1327673702436679741, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.化学药品改良型新药临床试验技术指导原则[EB/OL].[2021-01-28].https://www.cde.org.cn/zdyz/domesticinfopage?zdyzIdCODE=35d77016fdcd7dc0be456d8cf17ae238., articleTitle=null, refAbstract=null), Reference(id=1327673702499594302, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Allied Market Research.Opioids market by product(codeine, fentanyl, methadone, oxycodone, morphine, hydrocodone and others) and application (pain management, cough treatment, and diarrhea): global opportunity analysis and industry forecast, 2019-2026 [EB/OL].[2021-02-02].https://www.alliedmarketresearch.com/opioids-market., articleTitle=null, refAbstract=null), Reference(id=1327673702575091775, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=GuruFocus.Companies aiming for the billion-dollar opioid addiction market: the global opioid market is expected to reach $42.16 billion by 2021 [EB/OL].[2021-02-02].https://www.gurufocus.com/news/493086/companies-aiming-for-the-billiondollar-opioid-addiction-market., articleTitle=null, refAbstract=null), Reference(id=1327673702650589248, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=BUTLER S F, CASSIDY T A, CHILCOAT H, et al.Abuse rates and routes of administration of reformulated extended-release oxycodone: initial findings from a sentinel surveillance sample of individuals assessed for substance abuse treatment [J].J Pain, 2013, 14(4): 351-358., articleTitle=null, refAbstract=null), Reference(id=1327673702713503809, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=GEOFFREY SEVERTSON S, KREIDER S E D, AMIOKA E C, et al.Postmarketing analysis of misuse, abuse, and diversion of Xtampza ER [J].Pain Med, 2020, 21(12):3660-3668., articleTitle=null, refAbstract=null), Reference(id=1327673702784806978, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=格吕伦塔尔有限公司.防止滥用的剂型:中国,100577150C [P]. 2010-01-06., articleTitle=null, refAbstract=null), Reference(id=1327673702864498755, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=格吕伦塔尔有限公司.防止滥用的剂型:中国,1863513B[P]. 2013-01-16., articleTitle=null, refAbstract=null), Reference(id=1327673702935801924, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=广发医药研究小组.美国麻醉镇痛药行业专题之一:“奥施康定”后时代的仿制药格局[EB/OL].(2017-03-26)[2021-04-06].https://www.yaozui.com/p/220472., articleTitle=null, refAbstract=null), Reference(id=1327673703002910789, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=普渡制药公司.含有阿片类镇痛剂的抗篡改口服药物剂型:中国,101583360B [P].2014-02-26., articleTitle=null, refAbstract=null), Reference(id=1327673703061631046, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=普渡制药公司.包覆的抗篡改控制释放剂型:中国,103370058A [P].2013-10-23., articleTitle=null, refAbstract=null), Reference(id=1327673703141322823, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=OHEMO生命科学股份有限公司.抗滥用药物、使用方法和制备方法:中国,105534936B [P].2020-07-31., articleTitle=null, refAbstract=null), Reference(id=1327673703221014600, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=In the court of chancery of the state of delawar: memorandum opinion [EB/OL].[2021-04-6].https://www.morrisjames.com/assets/htmldocuments/Acela%20Investments%20v%20DiFalco.pdf., articleTitle=null, refAbstract=null), Reference(id=1327673703300706377, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=王洁,李军,苏心怡,等.阿片类药物的防滥用综述[J].中国生化药物杂志,2015,35(7):178-181., articleTitle=null, refAbstract=null), Reference(id=1327673703372009546, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=特色疗法股份有限公司.包括酶可剪切的酮改性的阿片样物质药物前体以及其可任选的抑制剂的组合物:中国,102695545B [P].2016-08-17., articleTitle=null, refAbstract=null), Reference(id=1327673703443312715, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=MUSTAFA A A, RAJAN R, SUAREZ J D, et al.A Review of the opioid analgesic benzhydrocodone-acetaminophen[J].Cureus, 2018, 10(6): e2844., articleTitle=null, refAbstract=null)], funds=[Fund(id=1327673699483889708, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, awardId=BM2019004, language=CN, fundingSource=江苏省中枢神经药物研究重点实验室资助项目(BM2019004), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1327673698049437714, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, xref=null, ext=[AuthorCompanyExt(id=1327673698057826323, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, companyId=1327673698049437714, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Nhwa Institute of Pharmaceutical Research, Jiangsu Nhwa Pharmaceutical Co., Ltd., Xuzhou 221116), AuthorCompanyExt(id=1327673698066214932, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, companyId=1327673698049437714, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=江苏恩华药业股份有限公司,恩华药物研究院,江苏 徐州 221116)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2022.01.004, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2022.01.004, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2022.01.004, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2022.01.004, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1641744000000, fullTextJson=null, articleText=null, reference=null)
收藏切换
防滥用阿片类镇痛药研究进展及专利分析
朱胜男 , 彭卫娟 , 许向阳 *
中国医药工业杂志 | 综述 2022,53(1): 48-55
收起
收藏切换
中国医药工业杂志 |综述 2022 , 53 (1) : 48 -55
防滥用阿片类镇痛药研究进展及专利分析
全屏
[Author(id=1327673698141712406, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327673698254958616, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, authorId=1327673698141712406, language=EN, stringName=Shengnan ZHU, firstName=Shengnan, middleName=null, lastName=ZHU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Nhwa Institute of Pharmaceutical Research, Jiangsu Nhwa Pharmaceutical Co., Ltd., Xuzhou 221116, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327673698334650393, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, authorId=1327673698141712406, language=CN, stringName=朱胜男, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=江苏恩华药业股份有限公司,恩华药物研究院,江苏 徐州 221116, bio={"content":"

朱胜男(1987-),女,硕士,工程师,从事新型镇痛药物的研究与开发。

"}, bioImg=null, bioContent=

朱胜男(1987-),女,硕士,工程师,从事新型镇痛药物的研究与开发。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327673698049437714, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, xref=null, ext=[AuthorCompanyExt(id=1327673698057826323, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, companyId=1327673698049437714, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Nhwa Institute of Pharmaceutical Research, Jiangsu Nhwa Pharmaceutical Co., Ltd., Xuzhou 221116), AuthorCompanyExt(id=1327673698066214932, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, companyId=1327673698049437714, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=江苏恩华药业股份有限公司,恩华药物研究院,江苏 徐州 221116)])]), Author(id=1327673698410147867, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327673698506616861, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, authorId=1327673698410147867, language=EN, stringName=Weijuan PENG, firstName=Weijuan, middleName=null, lastName=PENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Nhwa Institute of Pharmaceutical Research, Jiangsu Nhwa Pharmaceutical Co., Ltd., Xuzhou 221116, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327673698577920030, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, authorId=1327673698410147867, language=CN, stringName=彭卫娟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=江苏恩华药业股份有限公司,恩华药物研究院,江苏 徐州 221116, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327673698049437714, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, xref=null, ext=[AuthorCompanyExt(id=1327673698057826323, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, companyId=1327673698049437714, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Nhwa Institute of Pharmaceutical Research, Jiangsu Nhwa Pharmaceutical Co., Ltd., Xuzhou 221116), AuthorCompanyExt(id=1327673698066214932, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, companyId=1327673698049437714, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=江苏恩华药业股份有限公司,恩华药物研究院,江苏 徐州 221116)])]), Author(id=1327673698682777632, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=xuxiangyang@nhwa-group.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1327673698787635234, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, authorId=1327673698682777632, language=EN, stringName=Xiangyang XU, firstName=Xiangyang, middleName=null, lastName=XU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Nhwa Institute of Pharmaceutical Research, Jiangsu Nhwa Pharmaceutical Co., Ltd., Xuzhou 221116, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327673698858938403, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, authorId=1327673698682777632, language=CN, stringName=许向阳, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=江苏恩华药业股份有限公司,恩华药物研究院,江苏 徐州 221116, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327673698049437714, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, xref=null, ext=[AuthorCompanyExt(id=1327673698057826323, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, companyId=1327673698049437714, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Nhwa Institute of Pharmaceutical Research, Jiangsu Nhwa Pharmaceutical Co., Ltd., Xuzhou 221116), AuthorCompanyExt(id=1327673698066214932, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673695620935695, companyId=1327673698049437714, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=江苏恩华药业股份有限公司,恩华药物研究院,江苏 徐州 221116)])])]
朱胜男, 彭卫娟, 许向阳*
作者信息
  • 江苏恩华药业股份有限公司,恩华药物研究院,江苏 徐州 221116
通讯作者:
许向阳(1971-),男,博士,研究员,从事药物新制剂、新剂型和新技术的研究。Tel:0516-66668239 E-mail:
作者简介:

朱胜男(1987-),女,硕士,工程师,从事新型镇痛药物的研究与开发。

Recent Advances in Abuse-deterrent Opioid Analgesics and Patent Analysis
Shengnan ZHU, Weijuan PENG, Xiangyang XU*
Affiliations
  • Nhwa Institute of Pharmaceutical Research, Jiangsu Nhwa Pharmaceutical Co., Ltd., Xuzhou 221116
出版时间: 2022-01-10 doi: 10.16522/j.cnki.cjph.2022.01.004
文章导航
收藏切换

阿片类镇痛药是治疗中至重度疼痛的有效药物,但其潜在的成瘾性也使之成为常见的被滥用药物。随着阿片类药物使用的增加,滥用所导致的社会问题在全球范围内不断凸显。美国在阿片类药物防滥用制剂开发方面处于世界领先水平,为减少阿片类药物滥用,率先鼓励开发防滥用阿片类镇痛药。目前已开发了多种防滥用技术,包括形成物理/化学屏障、添加激动药/拮抗药、添加厌恶剂和制备前体药物等。虽然部分防滥用阿片类药物因各种原因撤市,但是总体对遏制阿片类药物的滥用起到了积极作用。本综述总结了近几年防滥用阿片类镇痛药的最新研究进展,并对重点品种进行了专利分析,以期为国内防滥用制剂的研发提供参考。

防滥用  /  阿片类药物  /  镇痛药  /  专利分析

Opioid analgesics are efficient drugs for moderate-to-severe pain treatment. However, they also become commonly abused drugs due to their potential addiction. Prescription opioids abuse has become a global health crisis with increasing clinical use. The development of prescription opioids with abuse-deterrent formulations(ADFs) has been encouraged by the U. S. government to reduce the abuse of prescription opioids, so the United States is a recognized leader in discovering the new dosage forms of opioid analgesics around the world. To deter prescription opioids abuse, a variety of anti-abuse technologies have been developed, including forming physical/chemical barriers, adding agonists/antagonists, adding aversions, and preparing prodrugs. Although several approved opioid ADFs have been withdrawn from the market for different reasons, ADFs have played a positive role in lowering overall abuse risks. This review summarizes the recent development of abuse-deterrent opioid analgesics and analyzes the patents of critical products, hoping to provide some references for the research and development of ADFs in China.

abuse-deterrent  /  prescription opioids  /  analgesics  /  patent analysis
朱胜男, 彭卫娟, 许向阳. 防滥用阿片类镇痛药研究进展及专利分析. 中国医药工业杂志, 2022 , 53 (1) : 48 -55 . DOI: 10.16522/j.cnki.cjph.2022.01.004
Shengnan ZHU, Weijuan PENG, Xiangyang XU. Recent Advances in Abuse-deterrent Opioid Analgesics and Patent Analysis[J]. Chinese Journal of Pharmaceuticals, 2022 , 53 (1) : 48 -55 . DOI: 10.16522/j.cnki.cjph.2022.01.004
  • 江苏省中枢神经药物研究重点实验室资助项目(BM2019004)
参考文献 引证文献
排序方式:
[1]
MILER R D.米勒麻醉学(第7版上卷)[M].邓小明,曾因明,译.北京:北京大学医学出版社,2011:781-796.
[2]
HAUMANN J, JOOSTEN E B A, VAN DEN BEUKEN-VAN EVERDINGEN M H J.Pain prevalence in cancer patients: status quo or opportunities for improvement? [J].Curr Opin Support Palliat Care, 2017, 11(2): 99-104.
[3]
HANNA M, MOON J Y.A review of dexketoprofen trometamol in acute pain [J].Curr Med Res Opin, 2019,35(2): 189-202.
[4]
世界卫生组织.阿片类药物过量[EB/OL].(2021-08-04).https://www.who.int/zh/news-room/fact-sheets/detail/opioid-overdose.
[5]
佚名.新冠肺炎对毒品市场的影响[EB/OL].[2021-04-07].https://wdr.unodc.org/wdr2020/field/V2002973_Exum_Chinese.pdf.
[6]
ADLER J A, MALLICK-SEARLE T.An overview of abuse-deterrent opioids and recommendations for practical patient care [J].J Multidiscip Healthc, 2018, 11: 323-332.
[7]
CARINCI A J.Abuse-deterrent opioid analgesics: a guide for clinicians [J].Pain manag, 2020, 10(1): 55-62.
[8]
GADD S, COX N, SAMUELSON J, et al.Abuse-deterrent opioid formulations and the opioid crisis: a pharmacist's perspective [J].Ther Drug Monit, 2021, 43(1): 35-41.
[9]
孟莉萍,王广平,易八贤.遏制滥用型阿片类镇痛药的研发进展[J].中国新药杂志,2015,24(18):2110-2121.
[10]
BUTREDDY A, NYAVANANDI D, NARALA S, et al.Application of hot melt extrusion technology in the development of abuse-deterrent formulations: an overview[J].Curr Drug Deliv, 2021, 18(1): 4-18.
[11]
徐一洲,柴旭煜,王健.阿片类药物防滥用技术研究进展[J].中国医药工业杂志,2021,52(6):719-727.
[12]
WEN L S, SADEGHI N B.The opioid crisis and the 2020 US election: crossroads for a national epidemic [J].Lancet,2020, 396(10259): 1316-1318.
[13]
央视新闻客户端.美国阿片类药物滥用危机正在恶化专家:政府解决问题就像“拆东墙补西墙”[EB/OL].[2021-02-08].https://m.news.cctv.com/2020/09/13/ARTIJLmXEgxUSsfRBxivvZbp200913.shtml.
[14]
U.S. Food and Drug Administration.Guidance for industry: abuse-deterrent opioids — evaluation and labeling [EB/OL].[2021-01-28].https://www.fda.gov/regulatory-information/search-fda-guidance-documents/abuse-deterrent-opioids-evaluation-and-labeling.
[15]
U.S. Food and Drug Administration.Guidance for industry: general principles for evaluating the abuse deterrence of generic solid oral opioid drug products [EB/OL].[2021-01-28].https://www.fda.gov/regulatory-information/search-fda-guidance-documents/general-principles-evaluating-abuse-deterrence-generic-solid-oral-opioid-drug-products-guidance.
[16]
支梦佳,魏兴梅,高翔,等.我国阿片类镇痛药物临床使用现状分析[J].药物流行病学杂志,2018,27(6):400-405.
[17]
国家药品监督管理局药品审评中心.化学药品改良型新药临床试验技术指导原则[EB/OL].[2021-01-28].https://www.cde.org.cn/zdyz/domesticinfopage?zdyzIdCODE=35d77016fdcd7dc0be456d8cf17ae238.
[18]
Allied Market Research.Opioids market by product(codeine, fentanyl, methadone, oxycodone, morphine, hydrocodone and others) and application (pain management, cough treatment, and diarrhea): global opportunity analysis and industry forecast, 2019-2026 [EB/OL].[2021-02-02].https://www.alliedmarketresearch.com/opioids-market.
[19]
GuruFocus.Companies aiming for the billion-dollar opioid addiction market: the global opioid market is expected to reach $42.16 billion by 2021 [EB/OL].[2021-02-02].https://www.gurufocus.com/news/493086/companies-aiming-for-the-billiondollar-opioid-addiction-market.
[20]
BUTLER S F, CASSIDY T A, CHILCOAT H, et al.Abuse rates and routes of administration of reformulated extended-release oxycodone: initial findings from a sentinel surveillance sample of individuals assessed for substance abuse treatment [J].J Pain, 2013, 14(4): 351-358.
[21]
GEOFFREY SEVERTSON S, KREIDER S E D, AMIOKA E C, et al.Postmarketing analysis of misuse, abuse, and diversion of Xtampza ER [J].Pain Med, 2020, 21(12):3660-3668.
[22]
格吕伦塔尔有限公司.防止滥用的剂型:中国,100577150C [P]. 2010-01-06.
[23]
格吕伦塔尔有限公司.防止滥用的剂型:中国,1863513B[P]. 2013-01-16.
[24]
广发医药研究小组.美国麻醉镇痛药行业专题之一:“奥施康定”后时代的仿制药格局[EB/OL].(2017-03-26)[2021-04-06].https://www.yaozui.com/p/220472.
[25]
普渡制药公司.含有阿片类镇痛剂的抗篡改口服药物剂型:中国,101583360B [P].2014-02-26.
[26]
普渡制药公司.包覆的抗篡改控制释放剂型:中国,103370058A [P].2013-10-23.
[27]
OHEMO生命科学股份有限公司.抗滥用药物、使用方法和制备方法:中国,105534936B [P].2020-07-31.
[28]
In the court of chancery of the state of delawar: memorandum opinion [EB/OL].[2021-04-6].https://www.morrisjames.com/assets/htmldocuments/Acela%20Investments%20v%20DiFalco.pdf.
[29]
王洁,李军,苏心怡,等.阿片类药物的防滥用综述[J].中国生化药物杂志,2015,35(7):178-181.
[30]
特色疗法股份有限公司.包括酶可剪切的酮改性的阿片样物质药物前体以及其可任选的抑制剂的组合物:中国,102695545B [P].2016-08-17.
[31]
MUSTAFA A A, RAJAN R, SUAREZ J D, et al.A Review of the opioid analgesic benzhydrocodone-acetaminophen[J].Cureus, 2018, 10(6): e2844.
2022年第53卷第1期
82
16
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2022.01.004
  • 接收时间:2021-03-09
  • 首发时间:2026-11-12
  • 出版时间:2022-01-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2021-03-09
基金
江苏省中枢神经药物研究重点实验室资助项目(BM2019004)
作者信息
    江苏恩华药业股份有限公司,恩华药物研究院,江苏 徐州 221116

通讯作者:

许向阳(1971-),男,博士,研究员,从事药物新制剂、新剂型和新技术的研究。Tel:0516-66668239 E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2022.01.004
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏